MICHAEL T MORRIS

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ATLANTA, GA NPI 1245409101

General Payments — all program years on this page

$6,718.47

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 219
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $660.88 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $660.8819

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,956.3445
2019 $242.8416
2020 $401.4922
2021 $726.6941
2022 $1,093.0949
2023 $637.1427
2024 $660.8819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077986536 Janssen Pharmaceuticals, Inc $16.26 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077987032 Janssen Pharmaceuticals, Inc $18.06 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080663453 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $17.54 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080664111 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $14.31 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087075478 Novartis Pharmaceuticals Corporation $22.37 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092395258 Boston Scientific Corporation $20.69 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092395260 Boston Scientific Corporation $139.30 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104422933 AstraZeneca Pharmaceuticals LP $32.51 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115946474 Amgen Inc. $14.01 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117931341 Boehringer Ingelheim Pharmaceuticals, Inc. $27.54 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120138230 Vital Connect, Inc $31.78 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120626258 Baxter Healthcare $82.33 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120626260 Baxter Healthcare $44.12 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124919137 Abbott Laboratories $28.54 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125857232 Alnylam Pharmaceuticals Inc. $21.43 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141585380 Merck Sharp & Dohme LLC $17.14 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141585382 Merck Sharp & Dohme LLC $25.68 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148085356 Inspire Medical Systems, Inc. $69.86 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154878460 Kiniksa Pharmaceuticals International, plc $17.41 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.